Verdad Advisers’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Verdad Advisers's BLTE Position: Q3 2026 in Review
Verdad Advisers reduced its Belite Bio (BLTE) stake by 72% in Q3 2026, selling an estimated $1.62M and leaving 3,795 shares worth $644K. The position accounts for 0.69% of the portfolio, ranked #46.
Verdad Advisers first reported a position in BLTE in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.2M in Q1 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Verdad Advisers held 3,795 shares of Belite Bio worth $644K as of Q3 2026.
- Verdad Advisers sold 9,963 Belite Bio shares in Q3 2026, an estimated $1.62M.
- Belite Bio made up 0.69% of Verdad Advisers's portfolio in Q3 2026, its #46 holding.
- Verdad Advisers first reported a position in Belite Bio in Q1 2026 and has held it in 3 quarters since.
- Verdad Advisers's Belite Bio position peaked at $2.2M in Q1 2026.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Verdad Advisers's 13F filing for Q3 2026, filed 16 Nov 2026.